Swiss Center for Electronics and Microtechnology

China Focus releases a new feature on CIIE Helps European SMEs Explore the Chinese Market

Retrieved on: 
Montag, Dezember 5, 2022

BEIJING, Dec. 5, 2022 /PRNewswire/ -- Over the past five years, the China International Import Expo (CIIE) has provided a platform for multinationals to exhibit their flagship products and services. It also offered a chance for foreign small and medium-sized enterprises (SMEs) to build their presence in the Chinese market. The 2022 CIIE welcomed many new faces of SMEs from Europe, which brought exotic specialties to Chinese consumers as well as opportunities for cooperation. 

Key Points: 
  • China Focus releases a new feature on CIIE Helps European SMEs Explore the Chinese Market.
  • It also offered a chance for foreign small and medium-sized enterprises (SMEs) to build their presence in the Chinese market.
  • France is the largest producer of agricultural products in the European Union (EU), and China is the world's largest food importer.
  • In the future, it is hoped that more Swiss companies can enter the Chinese market through the CIIE.

Biospectal Partners with Amref Health Africa to Extend Global Access to Blood Pressure Management

Retrieved on: 
Donnerstag, Oktober 6, 2022

Biospectals remote monitoring software puts easy, accurate and intelligent blood pressure monitoring at the literal fingertips of people around the world.

Key Points: 
  • Biospectals remote monitoring software puts easy, accurate and intelligent blood pressure monitoring at the literal fingertips of people around the world.
  • Biospectals OptiBP medical-grade mobile app uses a smartphone cameras optical lens to measure and record a users blood pressure via their fingertip.
  • Amref Health Africa began on the continent as the Flying Doctors, bringing surgical services to remote communities using light aircraft.
  • Amref Health Africa, is headquartered in Nairobi Kenya with offices in 35 countries in sub-Saharan Africa.

World's first automated 24/7 blood pressure monitor comes to the USA

Retrieved on: 
Dienstag, Januar 4, 2022

In the United States, nearly 50% of adults, about 116 million people, have high blood pressure.

Key Points: 
  • In the United States, nearly 50% of adults, about 116 million people, have high blood pressure.
  • Yet current measurement devices only capture a brief snapshot of overall blood pressure, and they are burdensome to use.
  • Aktiia'sOptical Blood Pressure Monitoring (OBPM) algorithms leverage optical sensors worn on the wrist and provide blood pressure values using photoplethysmography (PPG) toanalyzethe changing diameter of the arteries occurring at each heartbeat.
  • Founded in Switzerland in May 2018, Aktiia'steam has some of the world's leading scientific and technical experts in optical blood pressure monitoring.

Biospectal to Debut Biodisc and Launch OptiBP for iOS Public Beta at CES 2022

Retrieved on: 
Mittwoch, Dezember 8, 2021

Biospectal also plans to announce the public beta launch of Biospectal OptiBP for iOS at CES 2022, which will be available in the U.S., U.K., France, Germany, Spain and Switzerland, and follows the public beta launch of OptiBP for Android at CES 2021.

Key Points: 
  • Biospectal also plans to announce the public beta launch of Biospectal OptiBP for iOS at CES 2022, which will be available in the U.S., U.K., France, Germany, Spain and Switzerland, and follows the public beta launch of OptiBP for Android at CES 2021.
  • Our software-only approach with the Biospectal OptiBP app enables embodiment in different devices, and is now available in public beta for both Android and iOS users," said Biospectal CEO and co-founder, Eliott Jones.
  • "The Biospectal OptiBP app has the ability to turn the global network of smartphones into a medical-grade blood pressure monitoring platform.
  • It is a tech-free device that works together with the Biospectal OptiBP app and extends the reach of Biospectal's blood pressure monitoring platform.

Biospectal OptiBP Named Winner in Fast Company's First-Ever List of the Next Big Things in Tech

Retrieved on: 
Freitag, November 19, 2021

Biospectal OptiBP for iOS is currently in alpha and is planned for public beta launch in the second half of 2021.

Key Points: 
  • Biospectal OptiBP for iOS is currently in alpha and is planned for public beta launch in the second half of 2021.
  • While not all of the products, services, and technological developments are on the market yet, they're reaching key milestones.
  • Democratizing blood pressure management at global scale enables population scale improvement in addressing the most prevalent chronic health condition globally.
  • OptiBP records blood flow using a breakthrough optical signal processing algorithm to "see" the pulse and estimate blood pressure.

Aktiia® launches into healthcare market with $17.5M investment for its world-first 24-7 Blood Pressure Monitoring System

Retrieved on: 
Mittwoch, November 3, 2021

This Series A will be used to expand its offer to healthcare systems within these geographies as well as moving into new territories.

Key Points: 
  • This Series A will be used to expand its offer to healthcare systems within these geographies as well as moving into new territories.
  • In addition to endorsement by leading clinicians in hypertension management, Aktiia is now also an official partner of the International Society of Hypertension .
  • "Thisisan indisputable game changer inenabling abetter understanding of our patients' blood pressure patternsand how to treat themon apersonalizedbasis."
  • AboutAktiia:Founded in Switzerland in May 2018, Aktiia's team has some of the world's leading scientific and technical experts in optical blood pressure monitoring, including CTO, Dr. Josep Sola , a pioneer in cuffless blood pressure monitoring and editor of "The Handbook of Cuffless Blood Pressure Monitoring."

Biospectal OptiBP Honored in Fast Company's 2021 Innovation by Design Awards

Retrieved on: 
Freitag, Oktober 1, 2021

LAUSANNE, Switzerland and SAN FRANCISCO, Oct. 1, 2021 /PRNewswire-PRWeb/ -- Biospectal SA , the remote patient monitoring biosensing software company, today announced the Biospectal OptiBP smartphone blood pressure monitoring app and data platform was honored in Fast Company's Innovation by Design Awards for 2021 in the Health category .

Key Points: 
  • LAUSANNE, Switzerland and SAN FRANCISCO, Oct. 1, 2021 /PRNewswire-PRWeb/ -- Biospectal SA , the remote patient monitoring biosensing software company, today announced the Biospectal OptiBP smartphone blood pressure monitoring app and data platform was honored in Fast Company's Innovation by Design Awards for 2021 in the Health category .
  • Biospectal OptiBP for iOS is currently in alpha and is planned for public beta launch in the second half of 2021.
  • Highlighted in the October 2021 print issue of Fast Company, the 10th anniversary of the Innovation by Design awards recognizes people, teams, and companies that transform businesses, organizations and society through design.
  • "We are excited to be included in Fast Company's 2021 Innovation by Design Awards and to be recognized as an innovative company focused on solving the problems of today and tomorrow," said Biospectal CEO and co-founder, Eliott Jones.

Blood Pressure Monitoring Journal Publishes Clinical Study Results Validating the Accuracy of Biospectal OptiBP™

Retrieved on: 
Donnerstag, August 5, 2021

SAN FRANCISCO and LAUSANNE, Switzerland, Aug. 5, 2021 /PRNewswire-PRWeb/ -- Biospectal , the remote patient monitoring and biosensing software company, today announced the publication of clinical study results in Blood Pressure Monitoring Journal .

Key Points: 
  • SAN FRANCISCO and LAUSANNE, Switzerland, Aug. 5, 2021 /PRNewswire-PRWeb/ -- Biospectal , the remote patient monitoring and biosensing software company, today announced the publication of clinical study results in Blood Pressure Monitoring Journal .
  • The study results also reinforce the clinical accuracy of Biospectal's OptiBP software-based smartphone app solution to accurately measure blood pressure utilizing transdermal optical sensing with only a fingertip applied to the lens of a smartphone camera.
  • "Biospectal OptiBP makes a huge leap in the ease of blood pressure monitoring and management by enabling convenient, frequent monitoring capability via a smartphone app.
  • The Blood Pressure Monitoring Journal study demonstrates the accuracy of the Biospectal OptiBP smartphone app to estimate the blood pressure of participants using a standardized protocol set by the Association for the Advancement of Medical Instrumentation/European Society of Hypertension/International Organization for Standardization (AAMI/ESH/ISO).

EQS-News: Meyer Burger and CSEM extend collaboration for the joint development of novel solar cells and modules

Retrieved on: 
Freitag, Oktober 23, 2020

Meyer Burger Technology Ltd (SIX Swiss Exchange: MBTN) extends the existing collaboration with the Swiss research and development center CSEM.

Key Points: 
  • Meyer Burger Technology Ltd (SIX Swiss Exchange: MBTN) extends the existing collaboration with the Swiss research and development center CSEM.
  • The scientists from CSEM and Meyer Burger Research, the subsidiary responsible for research and development, have been working successfully on new technologies for the production of highly efficient solar cells and modules for more than seven years.
  • Fraunhofer ISE certified an efficiency of 25.4 percent for solar cells on standard industrial wafers manufactured at the Meyer Burger Research Center in Neuchtel, in close collaboration with CSEM.
  • The collaboration between Meyer Burger and CSEM originated in 2008 through a cooperation with the EPFL (cole polytechnique fdrale de Lausanne).